Cg Oncology OverviewCg Oncology EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CGON.
Quarterly EBIT
-$66.39M
↓ 57.3% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$207.57M
↓ 54.44% YoY
Trailing 12 months ending Mar 31, 2026
Cg Oncology OverviewEBIT (Earnings Before Interest and Taxes) analysis for CGON.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026